ScholarWorks@Korea University College of Medicine: Koh, Seong Beom

Detailed Information

Koh, Seong Beom(고성범)

Guro Hospital (Department of Neurology, Guro Hospital)

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Parkinson&apos:62||s disease:60||Parkinson’s disease:7||Parkinson disease:6||UPDRS:6||quantification:5||Gait:5||Quantification:5||rigidity:5||s Disease:4||stroke:4||tremor:4||Korea:4||Bradykinesia:4||depression:4||Quality of life:3||Stroke:3||Parkinsonism:3||dementia:3||Deep brain stimulation:3||Nonmotor symptoms:3||stereopsis:3||Angular velocity:3||Progressive supranuclear palsy:3||validation:3||viscoelasticity:3||cognition:3||quality of life:3||cognitive impairment:3||Gyro sensor:3||Idiopathic Parkinson&apos:2||rating scale:2||Biomarker:2||heart rate:2||epidural blood patch:2||ultrasonography:2||Sleep:2||gait analysis:2||Electrogoniometer:2||파킨슨병:2||ischemic stroke:2||Parkinson&:2||variability:2||acceleration:2||voxelbased morphometry:2||Impulse control disorder:2||positron emission tomography:2||Voxelbased morphometry:2||Korean version:2||Ldopa:2||zz:2||prevalence:2||primary progressive aphasia:2||Splenium:2||migraine:2||국내전문:2||gait:2||s DiseaseSleep:2||Idiopathic generalized epilepsy:2||Epidemiology:2||dopamine agonist:2||Cognitive impairment:2||hyposmia:2||Essential tremor:2||blood pressure:2||Scales for Outcomes in Parkinson&apos:2||Magnetic resonance imaging:2||Dopamine dysregulation syndrome:1||Dynamic balance:1||Dysautonomia:1||Dyskinesia:1||Dystonia:1||EARLYSTAGE:1||EMG:1||Early stage:1||EarlyOnset:1||Electrodiagnostic study:1||Electrophysiologic findings:1||Encephalopathy:1||Enkephalin:1||Episodic migraine:1||Evaluation:1||Excessive long duration:1||Executive function:1||Exploratory factor analysis:1||FALLS:1||Fat:1||Finger taps:1||Foot Scan System:1||Four square step test:1||Free fatty acid:1||Freezing of gait:1||Frontal cognitive dysfunction:1||Frontal executive dysfunction:1||Frontal executive function:1||Frontalexecutive function:1||GCH1:1||Gait analysis:1||Gait analysis program:1||Gait evaluation:1||Gaucher disease:1||Gender:1||Genetic risk factor:1||Genetics:1||Genetics  clinical:1||Glucocerebrosidase:1||Guanosine triphosphate cyclohydrolase 1:1||Gyrosensor:1||Hand Tremor Questionnaire:1||Hand rotation:1||Harmonisation:1||Headache:1||Helicobacter pylori:1||Hemiplegic patients:1||Hepatitis A virus:1||Herpes zoster:1||Hoehn &:1||Hydrocephalus:1||Hyperpyrexia:1||Hyponatremia:1||Hyposmia:1||Hypothalamus:1||IFNβ:1||IMPAIRMENT:1||INCIDENT DEMENTIA:1||Idiopathic facial mononeuropathy:1||Immunological damage:1||Impulse control disorders:1||Infarction:1||Influenza B virus:1||Internet:1||Intraoperative:1||Iron:1||Ischemic stroke:1||Isolated recurrent hypersomnia:1||Juvenile myoclonic epilepsy:1||Keywords Dance:1||LFP:1||Left temporoparietal lobe infarction:1||Leucinerich repeat kinase 2:1||Limb bradykinesia:1||Lithium:1||MANAGEMENT:1||MDCT angiography:1||MMPI:1||MOTOR SUBTYPE:1||MR diffusion image:1||MRI:1||Malignancy:1||Medication:1||Microelectrode:1||Microelectrode recording:1||Midbrain atrophy:1||Migraine:1||Migraine without aura:1||Mild cognitive impairment:1||Mirror writing:1||Monoamine oxidase B inhibitors:1||Mood:1||Motor:1||Motor phenotype:1||Motor signs:1||Movement Disorder Society Sponsored Revision of the Unified Parkinson&apos:1||Movement disorders:1||Multiple lower cranial nerve palsy:1||Multiple sclerosis:1||Multiple system atrophy:1||Muscle:1||Myasthenia gravis:1||Neural substrate:1||Neuralgia amyotrophy:1||Neurodegenerative diseases:1||Neurogenic orthostatic hypotension:1||Neuropsychiatric traits:1||Neuropsychological test:1||Nonmotor:1||Nonmotor symptoms:1||Obsessive compulsiveness:1||Orthostatic tremor:1||Osmotic demyelination:1||Outcome:1||PD (Parkinson&apos:1||PET (positron emission tomography):1||PET classifier:1||POSTUROGRAPHY:1||PSEN1 Thr116Ile mutation:1||Pantothenate kinaseassociated neurodegeneration:1||Parameters of Gait Analysis:1||Parkin Mutation:1||Parkinson rat model:1||Parkinsonism Hyperpyrexia Syndrome:1||Parkinson’s Disease (파킨슨씨 병):1||Pathological crying:1||Pathological laughing:1||Phenotype:1||Photophobia:1||Polymorphism:1||Ponstomidbrain ratio:1||Presymptomatic PSP:1||Prevalence:1||Progressive myoclonic epilepsy:1||Progressive myoclonus ataxia:1||Putamen:1||RADICULOMYELITIS:1||REM sleep behavior disorder:1||RISK:1||Rare variants:1||Regional volumetry:1||Repetitive behavior disorder:1||Residual sign:1||Restingstate functional connectivity:1||Richardson&apos:1||Rigidity:1||Rigidity (경직):1||Risk Factors:1||Risk factor:1||SARSCoV2:1||SCOPA Sleep:1||SCOPASleep:1||SKF38393:1||SWAY:1||Scale for Outcomes in Parkinson’s diseaseAutonomic:1||Severity:1||Shape analysis:1||Signs and Symptoms:1||Speed:1||Spinal cord tumor:1||Spinocerebellar ataxia:1||Spinocerebellar ataxia (SCA):1||Spinocerebellar ataxia 17:1||Spinocerebellar ataxia type 2:1||Strabismic amblyopia.:1||Stride length:1||Stride time:1||Subcortical grey matter:1||Subcortical vascular cognitive impairment:1||SubstanceP:1||Substantia nigra:1||Sunnybrook scale:1||Supranuclear vertical ophthalmoplegia:1||Surface electromyogram:1||Tension headache:1||Thalamocortical network:1||Thalamus:1||Thigh:1||Three dimensional:1||Thrombosis:1||Tinetti mobility test:1||Toe tapping:1||Tremor dominant:1||Triglycerides:1||Tuberculous meningitis:1||Validatio:1||Validation:1||Vascular events:1||Vertexbased shape analysis:1||Viscoelasticity (점탄성):1||Web sites:1||White matter integrity:1||Wounds and injuries:1||Yahr stage:1||aHuntington’s disease:1||accelerometry:1||amyloidbeta (A beta):1||angular velocity:1||anterior cingulate cortex:1||apos:1||ataxic gait.:1||atherosclerosis:1||attention:1||backward gait:1||balance.:1||betaamyloid:1||biomarker:1||body mass index (BMI):1||body temperature changes:1||bradykinesia:1||cardiometabolic syndrome:1||cardiometabolic syndromes:1||carotenoids:1||carotid stenosis:1||carotid stent:1||caudal epidural injection:1||cerebral artery stenosis:1||cerebral infarction:1||cerebral ischemia:1||cerebrospinal fluid:1||chiropractic manipulation:1||clinical assessment:1||clinical rating:1||clinical trial:1||cocontraction:1||cognitive function:1||color vision:1||comprehension:1||compulsive behavior:1||coronary artery disease:1||cortical atrophy:1||cortical thickness:1||cranial neuropathy:1||craniectomy:1||cutaneous silent period:1||de novo Parkinson&apos:1||detection system:1||difference:1||diffusion tensor imaging:1||diffusionweighted imaging (DWI):1||disease:1||disease progression:1||doubleblind randomized controlled trial:1||druginduced parkinsonism:1||echogenicity:1||elderly:1||electrogoniometer:1||endovascular stent:1||endovascular treatment:1||entacapone:1||essential tremor:1||excessive daytime sleepiness:1||extracranial artery stenosis:1||extrastriate cortex:1||extrastriate cortical atrophy:1||familial:1||fear of falling:1||fluoroscopy:1||freezing of gait:1||frequencydomain:1||frontal executive function:1||functional disability:1||fusion PETCT:1||gait disturbance:1||gastrointestinal dysfunction:1||generative naming:1||genomewide association studies:1||genomewide association study:1||genomic variants:1||grey matter:1||gyro sensor:1||hand:1||headache:1||health care:1||healthrelated quality of life:1||hemiplegic patients:1||hemodynamic depression:1||hepatitis C:1||hiccup:1||hippocampus:1||hospital:1||hypoglycemia:1||impulse control disorder:1||impulsive behavior:1||incidence:1||incidence rate:1||infection:1||inpatients:1||insula:1||intensive care:1||interictal glucose metabolism:1||intracranial artery stenosis:1||intracranial hypotension:1||language:1||language function test:1||latent class analysis:1||levodopa:1||levodopainduced dyskinesia:1||light sensitivity:1||magnetic resonance angiography:1||magnetic resonance spectroscopy:1||median nerve:1||methylphenidate:1||mobile application:1||modifiable risk factor:1||mood:1||mortality:1||motor fluctuations:1||motorized device:1||movement disorder:1||movement disorders:1||moyamoya disease:1||musculoskeletal ultrasound:1||mutation:1||neural substrate:1||neurological manifestation:1||neurolymphomatosis:1||nonmotor symptom:1||nonmotor symptoms:1||nonmotor symptoms scale:1||nonmotor symptom:1||object naming:1||olfactory:1||orthostatic headache:1||osteoporosis:1||oxidative stress:1||pain:1||pantothenate kinaseassociated neurodegeneration:1||parkinson disease:1||parkinsonian rigidity:1||paroxysmal kinesigenic dyskinesia:1||passive movement:1||passive shortening:1||passive stretching:1||perception:1||personality trait:1||phase contrast microscopies:1||phasedependency:1||polymorphic pleocytosis:1||polymorphism:1||precuneus:1||prefrontal cortex:1||presenilin1:1||progressionCRP:1||pulmonary function test:1||questionnaire:1||restless leg syndrome:1||restless legs syndrome:1||risk factor:1||ropinirole:1||#8217:1||s Disease Rating Scale:1||s Disease Sleep Scale2:1||s dementia:1||s diease:1||s disease dementia:1||s disease):1||s syndrome:1||screening:1||shoulder disorders:1||sleep:1||sleepiness:1||small fiber neuropathy:1||somatosensory cortex:1||sonography:1||spinal cord:1||splenectomy:1||splenium:1||stepwise multiple regression:1||structural MRI:1||subcortical vascular cognitive impairment:1||survey:1||symptom:1||tau:1||thalamus:1||thrombotic angiopathy:1||timedomain:1||transcranial brain sonography:1||treatment:1||tubercular meningitis:1||unstable hemoglobinopathy:1||upper body:1||urinary symptoms:1||validation study:1||validity:1||wearingoff:1||white matter hyperintensities:1||without staining procedure:1||young onset Alzheimer&apos:1||z:1||가슴샘 과다증식증:1||감별진단:1||갑상선 기능항진증:1||국내논문:1||긴장형두통:1||뇌졸중:1||리튬:1||약물치료:1||전문지:1||전문학술지논문:1||중증 근무력증:1||증례:1||클라인 레빈 증후군:1||파킨슨 증후군의 역학조사:1||ryanodine receptor:1||11CRaclopride:1||A beta positivity:1||Acute autonomic and sensory neuropathy:1||Acyclovir:1||Allele frequency:1||Alzheimer&apos:1||Amblyopia:1||Amplitude:1||Amyloidbeta:1||Amyloidbeta (A beta):1||Anisometropic amblyopia:1||Arm and leg swings:1||Arm swing:1||Armswing:1||Asymmetry:1||Attention:1||Atypical parkinsonism:1||Autoimmune disease:1||Autonomic:1||Autonomic dysfunction:1||Autosomal dominant:1||Awareness:1||BALANCE:1||BMI change:1||BMI variability:1||Brachial plexus inflammation:1||Brain infarction:1||Brain injuries:1||CD14:1||COVID19:1||CT coronary angiography:1||Cadence:1||Cardioembolism:1||Carniocervical segmental dystonia:1||Ceramic gyrosensor:1||Cerebellar hemorrhage:1||Cerebrovascular complication:1||Chronic inflammatory demyelinating polyneuropathy:1||Cognitive dysfunction:1||ColletSicard syndrome:1||Common complex disease:1||Concordance:1||Constipation:1||Consultation:1||Cortical atrophy:1||Cortical thinning:1||CreutzfeldtJakob disease:1||DA9701:1||DBS:1||DBS (뇌심부 자극술):1||DBS surgery:1||DHDDS mutation:1||DISORDERS:1||Depression:1||Deprivational amblyopia:1||Dexmedetomidine:1||Difference:1||Diffusion tensor imaging:1||Dissociated horizontal deviation:1||Dissociation:1||Dopa responsive dystonia:1||Dopamine D2 receptors:1||Dopamine D3 receptors:1||Dopamine Depletion:1||Dopamine Dysregulation Syndrome:1||Dopamine agonist:1||

STATISTICS: Total View :7,738,690; Today View :600

RSS_1.0 RSS_2.0 ATOM_1.0

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841) 82-2-2286-1265

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE